Dexcom
Company Growth (employees)
Dexcom was founded in 1999 and is headquartered in San Diego, US
Dexcom Office Locations
Dexcom has an office in San Diego
San Diego, US (HQ)
6340 Sequence Dr
Dexcom Metrics
Dexcom Financial Metrics
Dexcom's revenue was reported to be $573.3 m in FY, 2016 which is a 43% increase from the previous period.
Revenue (FY, 2016) | $573.3 m |
Revenue growth (FY, 2015 - FY, 2016), % | 43% |
Gross profit (FY, 2016) | $378.4 m |
Gross profit margin (FY, 2016), % | 66% |
Net income (FY, 2016) | ($65.6 m) |
EBIT (FY, 2016) | ($63.9 m) |
Market capitalization (23-May-2017) | $5.8 b |
Closing share price (23-May-2017) | $68.9 |
Cash (31-Dec-2016) | $94.5 m |
EV | $5.7 b |
Dexcom's current market capitalization is $5.8 b.
- Source: SEC Filings
| FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | |
|---|---|---|---|---|
Revenue | $160 m | $259.2 m | $402 m | $573.3 m |
Revenue growth, % | 62% | 55% | 43% | |
Cost of goods sold | $59.9 m | $82.9 m | $123.6 m | $194.9 m |
Gross profit | $100.1 m | $176.3 m | $278.4 m | $378.4 m |
Gross profit Margin, % | 63% | 68% | 69% | 66% |
Operating expense total | $129 m | $197.8 m | $335.5 m | $442.3 m |
EBIT | ($28.9 m) | ($21.5 m) | ($57.1 m) | ($63.9 m) |
EBIT margin, % | (18%) | (8%) | (14%) | (11%) |
Interest expense | $900 k | $800 k | $400 k | $700 k |
Interest income | $400 k | |||
Pre tax profit | ($29.8 m) | ($22.3 m) | ($57.5 m) | ($64.9 m) |
Income tax expense | $100 k | $100 k | $100 k | $700 k |
Net Income | ($29.8 m) | ($22.4 m) | ($57.6 m) | ($65.6 m) |
- Source: SEC Filings
| FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | |
|---|---|---|---|---|
Cash | $43.2 m | $71.8 m | $86.1 m | $94.5 m |
Accounts Receivable | $26.1 m | $42.4 m | $74.1 m | $101.7 m |
Inventories | $9 m | $16 m | $35.2 m | $45.4 m |
Current Assets | $93.1 m | $145.9 m | $231.3 m | $280 m |
PP&E | $20.7 m | $31.2 m | $54.7 m | $109.4 m |
Goodwill | $3.2 m | $3.2 m | $3.7 m | $11.3 m |
Total Assets | $122.5 m | $184.6 m | $292 m | $402.8 m |
Total Debt | $6.8 m | $4.6 m | $2.3 m | |
Current Liabilities | $32.1 m | $40.6 m | $66.9 m | $102.4 m |
Additional Paid-in Capital | $559.5 m | $638 m | $776.8 m | $905.7 m |
Retained Earnings | ($475.4 m) | ($497.8 m) | ($555.4 m) | ($621 m) |
Total Equity | $84.1 m | $140.2 m | $221.2 m | $283.8 m |
Debt to Equity Ratio | 0.1 x | 0 x | 0 x | |
Debt to Assets Ratio | 0.1 x | 0 x | 0 x | |
Financial Leverage | 1.5 x | 1.3 x | 1.3 x | 1.4 x |
| FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | |
|---|---|---|---|---|
Net Income | ($29.8 m) | ($22.4 m) | ($57.6 m) | ($65.6 m) |
Depreciation and Amortization | $7 m | $8.4 m | $10.8 m | $15 m |
Accounts Receivable | ($6.5 m) | ($16 m) | ($32 m) | ($27 m) |
Inventories | ($1.6 m) | ($7 m) | ($19 m) | ($9.8 m) |
Cash From Operating Activities | $2.4 m | $23.6 m | $49 m | $56.2 m |
Purchases of PP&E | ($7.9 m) | ($16.2 m) | ($33.3 m) | ($55.7 m) |
Cash From Investing Activities | $20.9 m | ($16.8 m) | ($51.5 m) | ($55.9 m) |
Long-term Borrowings | ($200 k) | ($2.2 m) | ($2.3 m) | ($2.3 m) |
Cash From Financing Activities | $11.8 m | $21.8 m | $16.8 m | $8.1 m |
Interest Paid | $500 k | $400 k | $300 k | $100 k |
| Y, 2016 | |
|---|---|
EV/EBIT | -89.9 x |
EV/CFO | 102.2 x |
Financial Leverage | 1.4 x |
Dexcom Operating Metrics
| FY, 2016 | |
|---|---|
Patents (US) | 334 |
Patents (foreign) | 48 |
Patents Pending | 417 |
Trademarks (US) | 24 |
Trademarks Foreign | 54 |
Trademarks Pending | 38 |
Facilities | 2 |
- Source: SEC Filings
Dexcom Market Value History
Dexcom Revenue Breakdown
Dexcom Job Categories
Dexcom Median Salaries
Source: 23 public H-1B filings from Dexcom
